FDA’s Vaccine Safety Scandal: MenQuadfi Approved for 6-Week-Old Infants with ZERO Placebo Trials!

The FDA just approved Sanofi’s MenQuadfi meningococcal vaccine for infants as young as 6 weeks, but there’s a massive catch: NO placebo-controlled trials! We dive into the “vaccine placebo pyramid scheme,” where MenQuadfi was tested against Menveo, Menveo against Menactra, and Menactra against Menomune—none with a true placebo. Shockingly, 5.3% of infants in MenQuadfi trials (1 in 20) faced serious adverse events, yet the FDA calls it “safe.” We unpack the package inserts, expose the circular safety game, and reveal how the FDA’s fast-track voucher program might be putting speed over safety. Parents, this is a must-watch to understand what’s really going on with childhood vaccines. Demand transparency! #VaccineSafety #FDAExposed #MenQuadfi #ParentalRights